PREVENT Program for Hip Fractures
Trial Summary
What is the purpose of this trial?
Hip fractures occur nearly twice as often for older adults residing in long-term care as they do in older adults of a similar age still living in other settings. Hip fractures are the leading cause of hospitalization and often result in loss of independence, problems with walking and sometimes death. To address this problem the PREVENT (Person-centered Routine Fracture PrEVENTion in LTC) program was designed for use in long-term care homes. PREVENT uses a tool ("fracture risk calculator") based on a residents electronic health record to capture who is most at risk of fracture due to osteoporosis and falls. The program then trains the health care team including doctors, pharmacists and nurses on the latest recommendations on how to best assist residents and their families in making treatment decisions. The healthcare teams are also given tools that help them stay on track such as templates for ordering medications, strategies to reduce falls and fractures and making care plans. The study will examine if this program is effective for decreasing hip fractures by assigning some homes to receive the PREVENT program (intervention group) and some homes to usual care (control group) and comparing the results.
Will I have to stop taking my current medications?
The trial information does not specify whether participants must stop taking their current medications. It seems likely that participants can continue their current medications, as the program focuses on training healthcare teams to make treatment decisions.
What data supports the effectiveness of the PREVENT Program treatment for hip fractures?
The PREVENT Program treatment for hip fractures in long-term care facilities is supported by research indicating that interventions, including both non-drug and drug strategies, are needed to prevent fractures in these settings. Additionally, effective osteoporosis care, which is crucial for preventing hip fractures, involves early initiation and coordination of treatment, including calcium and vitamin D supplementation, and has shown benefits in improving patient outcomes.12345
Is the PREVENT Program for Hip Fractures safe for humans?
How is the PREVENT Program treatment for hip fractures different from other treatments?
The PREVENT Program is unique because it focuses on person-centered care specifically in long-term care facilities, addressing the unique needs of residents who have different access to medical services compared to those living independently. It emphasizes fall and fracture prevention strategies tailored to this setting, which is not typically the focus of standard treatments like medication or supplements.29101112
Research Team
Alexandra Papaioannou, MD, MSc
Principal Investigator
McMaster University
Eligibility Criteria
The PREVENT trial is for older adults in long-term care homes in Ontario and Alberta who are at risk of hip fractures due to osteoporosis and falls. Homes must have at least 70 residents to join. The study will use health records to identify eligible participants.Inclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Implementation of the PREVENT program in long-term care homes, including training healthcare teams and using a fracture risk calculator
Control
Homes in the control group receive usual care without the PREVENT program
Follow-up
Participants are monitored for safety and effectiveness after the intervention
Treatment Details
Interventions
- PREVENT Program (Behavioral Intervention)
Find a Clinic Near You
Who Is Running the Clinical Trial?
McMaster University
Lead Sponsor
Evan Stein
McMaster University
Chief Medical Officer since 2015
MD, PhD
Sam
McMaster University
Chief Executive Officer since 2023
MBA from McMaster University